🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

HCA Healthcare (HCA) Q4 Earnings Miss Estimates

Published 01/29/2018, 09:56 PM
Updated 07/09/2023, 06:31 AM
HCA
-
BTC/USD
-

Have you been eager to see how HCA Healthcare, Inc. (NYSE:HCA) performed in Q4 in comparison with the market expectations?

Let’s quickly scan through the key facts from this leading hospital company’s earnings release this morning.

Earnings Miss Estimates

HCA Healthcare came out with adjusted earnings per share of $1.30, that missed the Zacks Consensus Estimate of $1.86. Earnings declined nearly 45% year over year.

HCA Holdings, Inc. Price and EPS Surprise

How Was the Estimate Revision Trend?

You should note that the earnings estimate for HCA Healthcare depicted neutral stance prior to the earnings release. The Zacks Consensus Estimate remained unchanged at $1.86 per share over the last 7 days.

Overall, the company missed the Zacks Consensus Estimate in three of the last four quarters with an average miss of 8.6%.

Revenues Beat Estimates

HCA Healthcare posted revenues of $11.6 billion, that surpassed the Zacks Consensus Estimate of $11.2 billion. The reported figure was up from 8.6% from the year-ago quarter.

Key Stats to Note

Adjusted EBITDA totaled $2.4 billion up 7.1% year over year.

Same facility equivalent admissions increased 2.3% year over year, while same facility admissions increased 1.4%. Same facility revenue per equivalent admission increased 3.5%.

Expenses increased 12% year over year to $10.2 billion.

As of Dec 31, 2017, HCA Healthcare operated 179 hospitals and 120 freestanding surgery centers.

2018 Guidance

The company expects 2018 revenues in the range of $45 billion -$46 billion, adjusted EBIDTA of $ 8.45–$8.75 billion, EPS of $8.50–$9.00 and capital expenditures of about $3.5 billion.

What Zacks Rank Says

HCA Healthcare carries a Zacks Rank #3 (Hold). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Check back later for our full write up on this HCA Healthcare earnings report!

Don’t Even Think About Buying Bitcoin Until You Read This

The most popular cryptocurrency skyrocketed last year, giving some investors the chance to bank 20X returns or even more. Those gains, however, came with serious volatility and risk. Bitcoin sank 25% or more 3 times in 2017.

Zacks has just released a new Special Report to help readers capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly.

See 4 crypto-related stocks now >>



HCA Holdings, Inc. (HCA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.